Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   


The Angels Initiative

Stroke prevention


  Obstructive Lung Diseases

  Free Subscription


Articles published in Eur Respir J

Retrieve available abstracts of 276 articles:
HTML format



Single Articles


    June 2022
  1. SHOEMARK A, Griffin H, Wheway G, Hogg C, et al
    Genome sequencing reveals underdiagnosis of primary ciliary dyskinesia in bronchiectasis.
    Eur Respir J. 2022 Jun 21. pii: 13993003.00176-2022.
    PubMed     Abstract available


  2. CHANG AB, Zacharasiewicz A, Goyal V, Boyd J, et al
    Task Force report: European Respiratory Society statement for defining respiratory exacerbations in children and adolescents with bronchiectasis for clinical trials.
    Eur Respir J. 2022 Jun 21. pii: 13993003.00300-2022.
    PubMed     Abstract available



  3. "International ERS/ATS guidelines on definition, evaluation and treatment of severe asthma." Kian Fan Chung, Sally E. Wenzel, Jan L. Brozek, et al. Eur Respir J 2014; 43: 343-373.
    Eur Respir J. 2022;59.
    PubMed    


  4. CAZZOLA M, Martinez-Garcia MA, Matera MG
    Bronchodilators in bronchiectasis: there is light but it is still too dim.
    Eur Respir J. 2022;59.
    PubMed    


  5. CHANG AB, Boyd J, Bush A, Hill AT, et al
    International consensus statement on quality standards for managing children/adolescents with bronchiectasis from the ERS CRC Child-BEAR-Net.
    Eur Respir J. 2022;59.
    PubMed    


  6. YUGE M, Hori S, Ushida K, Momosaki R, et al
    Karaoke as a feasible alternative therapy to pulmonary rehabilitation for COPD.
    Eur Respir J. 2022;59.
    PubMed    


  7. LOKKE A, Kaasgaard M, Andreasson KH, Rasmussen DB, et al
    Reply: The effectiveness of singing versus exercise training.
    Eur Respir J. 2022;59.
    PubMed    


  8. VAES AW, Spruit MA, Franssen FME, van 't Hul AJ, et al
    The efficacy of singing versus exercise training: do the data really support the authors' conclusions?
    Eur Respir J. 2022;59.
    PubMed    


  9. BATEMAN ED, Price DB, Wang HC, Schonffeldt P, et al
    Reply to: Cause or consequence?
    Eur Respir J. 2022;59.
    PubMed    


  10. VOLPE FM
    Cause or consequence?
    Eur Respir J. 2022;59.
    PubMed    


    May 2022
  11. WOEHLK C, Von Bulow A, Ghanizada M, Baastrup Sondergaard M, et al
    Allergen immunotherapy effectively reduces the risk of exacerbations and lower respiratory tract infections in both seasonal and perennial allergic asthma: a nationwide epidemiological study.
    Eur Respir J. 2022 May 26. pii: 13993003.00446-2022.
    PubMed     Abstract available


  12. SUN Y, Zhang M, Ou Z, Meng Y, et al
    Indoor microbiome, microbial and plant metabolites, chemical compounds and asthma symptoms in junior high school students: a multicentre association study in Malaysia.
    Eur Respir J. 2022 May 26. pii: 13993003.00260-2022.
    PubMed     Abstract available


  13. HUMBERT M, Bourdin A, Taille C, Kamar D, et al
    Real-life omalizumab exposure and discontinuation in a large nationwide population-based study of pediatric and adult asthmatics.
    Eur Respir J. 2022 May 26. pii: 13993003.03130-2021.
    PubMed     Abstract available


  14. HABENER A, Grychtol R, Gaedcke S, DeLuca D, et al
    IgA(+) memory B cells are significantly increased in patients with asthma and small airways dysfunction.
    Eur Respir J. 2022 May 20. pii: 13993003.02130-2021.
    PubMed     Abstract available


  15. KROES JA, Zielhuis SW, De Jong K, Hashimoto S, et al
    Cumulative Corticosteroid Sparing Effect of Anti-Interleukin-5/5Ra In Eosinophilic Asthma.
    Eur Respir J. 2022 May 20. pii: 13993003.02983-2021.
    PubMed     Abstract available


  16. KOEHLER P, von Stillfried S, Garcia Borrega J, Fuchs F, et al
    Aspergillus tracheobronchitis in COVID-19 patients with acute respiratory distress syndrome: a cohort study.
    Eur Respir J. 2022;59.
    PubMed    


  17. MATHIOUDAKIS AG, Abroug F, Agusti A, Ananth S, et al
    ERS statement: a core outcome set for clinical trials evaluating the management of COPD exacerbations.
    Eur Respir J. 2022;59.
    PubMed     Abstract available


  18. GAIETTO K, Han YY, Forno E, Bacharier LB, et al
    Violence-related distress and lung function in two longitudinal studies of youth.
    Eur Respir J. 2022;59.
    PubMed     Abstract available


  19. LATIMER LE, Constantin-Teodosiu D, Popat B, Constantin D, et al
    Whole-body and muscle responses to aerobic exercise training and withdrawal in ageing and COPD.
    Eur Respir J. 2022;59.
    PubMed     Abstract available


  20. SORIANO JB, Hopkinson NS
    Sing out for COPD!
    Eur Respir J. 2022;59.
    PubMed    


  21. VESTBO J, Waterer G, Leather D, Crim C, et al
    Mortality after admission with pneumonia is higher than after admission with an exacerbation of COPD.
    Eur Respir J. 2022;59.
    PubMed    


  22. YUN JH, Lee S, Srinivasa P, Morrow J, et al
    An interferon-inducible signature of airway disease from blood gene expression profiling.
    Eur Respir J. 2022;59.
    PubMed     Abstract available


  23. KAASGAARD M, Rasmussen DB, Andreasson KH, Hilberg O, et al
    Use of Singing for Lung Health as an alternative training modality within pulmonary rehabilitation for COPD: a randomised controlled trial.
    Eur Respir J. 2022;59.
    PubMed     Abstract available


  24. FAIZ A, van den Berge M
    Quality over quantity: the importance of collecting relevant samples to understand complex diseases.
    Eur Respir J. 2022;59.
    PubMed    


  25. HIGHAM A, Beech A, Jackson N, Lea S, et al
    Sputum cell counts in COPD patients who use electronic cigarettes.
    Eur Respir J. 2022;59.
    PubMed    


  26. XU F, Vasilescu DM, Kinose D, Tanabe N, et al
    The molecular and cellular mechanisms associated with the destruction of terminal bronchioles in COPD.
    Eur Respir J. 2022;59.
    PubMed     Abstract available


    April 2022
  27. RABE KF, Pavord ID, Castro M, Wechsler ME, et al
    Dupilumab efficacy and safety in patients with asthma and blood eosinophils >/=500 cells.microL(-1).
    Eur Respir J. 2022 Apr 29. pii: 13993003.02577-2021.
    PubMed    


  28. VAN MEEL ER, Mensink-Bout SM, den Dekker HT, Ahluwalia TS, et al
    Early-life respiratory tract infections and the risk of school-age lower lung function and asthma: a meta-analysis of 150 000 European children.
    Eur Respir J. 2022 Apr 29. pii: 13993003.02395-2021.
    PubMed     Abstract available


  29. MENSINK-BOUT SM, van Meel ER, de Jongste JC, Annesi-Maesano I, et al
    Maternal diet in pregnancy and child's respiratory outcomes: an individual participant data meta-analysis of 18 000 children.
    Eur Respir J. 2022;59.
    PubMed     Abstract available


  30. SKRONSKA-WASEK W, Durlanik S, Le HQ, Schroeder V, et al
    The antimicrobial peptide S100A8/A9 produced by airway epithelium functions as a potent and direct regulator of macrophage phenotype and function.
    Eur Respir J. 2022;59.
    PubMed     Abstract available


  31. SINGH D, Beier J, Astbury C, Belvisi MG, et al
    The novel bronchodilator navafenterol: a phase 2a, multicentre, randomised, double-blind, placebo-controlled crossover trial in COPD.
    Eur Respir J. 2022;59.
    PubMed     Abstract available


    March 2022
  32. THOMAS D, McDonald VM, Pavord ID, Gibson PG, et al
    Asthma remission- what is it and how can it be achieved?
    Eur Respir J. 2022 Mar 31. pii: 13993003.02583-2021.
    PubMed     Abstract available


  33. SCHILDKNECHT K, Winthrop KL, Prevots DR, Blakney R, et al
    Nontuberculous mycobacterial pulmonary disease incidence among elderly patients with bronchiectasis.
    Eur Respir J. 2022 Mar 31. pii: 13993003.00018-2022.
    PubMed    


  34. HUYNH C, Whitmore GA, Vandemheen KL, FitzGerald JM, et al
    Derivation and Validation of the UCAP-Q Case-finding Questionnaire to Detect Undiagnosed Asthma and COPD.
    Eur Respir J. 2022 Mar 24. pii: 13993003.03243-2021.
    PubMed     Abstract available


  35. HAN YY, Yan Q, Chen W, Celedon JC, et al
    Child maltreatment, anxiety and depression, and asthma among British adults in the UK Biobank.
    Eur Respir J. 2022 Mar 17. pii: 13993003.03160-2021.
    PubMed     Abstract available


  36. BAL C, Idzko M, Skrgat S, Koch A, et al
    FeNO is associated with disease burden in the German Asthma Net severe asthma cohort.
    Eur Respir J. 2022 Mar 10. pii: 13993003.01233-2021.
    PubMed    


  37. KLEIN DK, Silberbrandt A, Frossing L, Hvidtfeldt M, et al
    Impact of former smoking exposure on airway eosinophilic activation and autoimmunity in patients with severe asthma.
    Eur Respir J. 2022 Mar 2. pii: 13993003.02446-2021.
    PubMed     Abstract available


  38. VONK JM, Roukema J
    Air pollution susceptibility in children with asthma and obesity: tidal volume as key player?
    Eur Respir J. 2022;59.
    PubMed    


  39. POLVERINO F
    Adaptive immune responses and protein homeostasis in COPD: the immunoproteasome.
    Eur Respir J. 2022;59.
    PubMed    


  40. THAMRIN C, Robinson PD, Farah CS, King GG, et al
    Technical standards for respiratory oscillometry and bronchodilator response cut-offs.
    Eur Respir J. 2022;59.
    PubMed    


  41. KAMMERL IE, Hardy S, Flexeder C, Urmann A, et al
    Activation of immune cell proteasomes in peripheral blood of smokers and COPD patients: implications for therapy.
    Eur Respir J. 2022;59.
    PubMed     Abstract available


  42. DAGHER R, Kumar V, Copenhaver AM, Gallagher S, et al
    Novel mechanisms of action contributing to benralizumab's potent anti-eosinophilic activity.
    Eur Respir J. 2022;59.
    PubMed     Abstract available


    February 2022
  43. MAISON N, Omony J, Illi S, Thiele D, et al
    T-high asthma phenotypes across life span.
    Eur Respir J. 2022 Feb 24. pii: 13993003.02288-2021.
    PubMed     Abstract available


  44. ALI GB, Lowe AJ, Perret JL, Walters EH, et al
    Impact of lifetime body mass index trajectories on the incidence and persistence of adult asthma.
    Eur Respir J. 2022 Feb 24. pii: 13993003.02286-2021.
    PubMed     Abstract available


  45. MORTIMER K, Reddel HK, Pitrez PM, Bateman ED, et al
    Asthma management in low- and middle-income countries: case for change.
    Eur Respir J. 2022 Feb 24. pii: 13993003.03179-2021.
    PubMed     Abstract available


  46. MORTIMER K, Lesosky M, Garcia-Marcos L, Innes Asher M, et al
    The burden of asthma, hay fever and eczema in adults in 17 countries: GAN Phase I study.
    Eur Respir J. 2022 Feb 24. pii: 13993003.02865-2021.
    PubMed     Abstract available


  47. MOSLEMI A, Kontogianni K, Brock J, Wood S, et al
    Differentiating COPD and Asthma using Quantitative CT Imaging and Machine Learning.
    Eur Respir J. 2022 Feb 24. pii: 13993003.03078-2021.
    PubMed     Abstract available


  48. LOUIS R, Satia I, Ojanguren I, Schleich F, et al
    European Respiratory Society Guidelines for the Diagnosis of Asthma in Adults.
    Eur Respir J. 2022 Feb 15. pii: 13993003.01585-2021.
    PubMed     Abstract available


  49. SKOV IR, Madsen H, Henriksen DP, Andersen JH, et al
    Low dose oral corticosteroids in asthma associates with increased morbidity and mortality.
    Eur Respir J. 2022 Feb 10. pii: 13993003.03054-2021.
    PubMed     Abstract available


  50. TAYTARD J, Koskas M, Beydon N
    Spirometry forced expiratory time is driven by airflow limitation in asthmatic children.
    Eur Respir J. 2022 Feb 10. pii: 13993003.02620-2021.
    PubMed    


  51. GARCIA-MARCOS L, Innes Asher M, Pearce N, Ellwood E, et al
    The burden of asthma, hay fever and eczema in children in 25 countries: GAN Phase I study.
    Eur Respir J. 2022 Feb 10. pii: 13993003.02866-2021.
    PubMed     Abstract available


  52. MARCON A, Locatelli F, Accordini S
    The coexistence of asthma and COPD: some considerations about prevalence and lung function decline.
    Eur Respir J. 2022 Feb 3. pii: 13993003.00096-2022.
    PubMed    


  53. KEARNS N, Bruce P, Williams M, Doppen M, et al
    Repeated dose budesonide/formoterol compared to salbutamol in adult asthma: A randomised cross-over trial.
    Eur Respir J. 2022 Feb 3. pii: 13993003.02309-2021.
    PubMed     Abstract available


  54. SEYS SF, Long MB
    The quest for biomarkers in asthma: challenging the T2 versus non-T2 paradigm.
    Eur Respir J. 2022;59.
    PubMed    


  55. ZHANG PD, Zhang XR, Zhang A, Li ZH, et al
    Associations of genetic risk and smoking with incident COPD.
    Eur Respir J. 2022;59.
    PubMed     Abstract available


  56. FRANCIOSI AN, Fraughen D, Carroll TP, McElvaney NG, et al
    Alpha-1 antitrypsin deficiency: clarifying the role of the putative protective threshold.
    Eur Respir J. 2022;59.
    PubMed     Abstract available


    January 2022
  57. PARASKAKIS E, Sarikloglou E, Fouzas S, Steiropoulos P, et al
    Improved prediction of asthma exacerbations by measuring distal airway inflammation.
    Eur Respir J. 2022 Jan 27. pii: 13993003.01684-2021.
    PubMed    


  58. RICCARDI D, Ward JP, Yarova PL, Janssen LJ, et al
    Topical therapy with negative allosteric modulators of the calcium-sensing receptor (calcilytics) for the management of asthma: the beginning of a new era?
    Eur Respir J. 2022 Jan 20. pii: 13993003.02103-2021.
    PubMed     Abstract available


  59. AL-SHAIKHLY T, Murphy RC, Parker A, Lai Y, et al
    Location of eosinophils in the airway wall is critical for specific features of airway hyperresponsiveness and T2 inflammation in asthma.
    Eur Respir J. 2022 Jan 13. pii: 13993003.01865-2021.
    PubMed     Abstract available


  60. PEROTIN JM, Wheway G, Tariq K, Azim A, et al
    Vulnerability to acid reflux of the airway epithelium in severe asthma.
    Eur Respir J. 2022 Jan 7. pii: 13993003.01634-2021.
    PubMed     Abstract available


  61. RAMIS J, Middlewick R, Pappalardo F, Cairns JT, et al
    Lysyl oxidase-like 2 is increased in asthma and contributes to asthmatic airway remodelling.
    Eur Respir J. 2022 Jan 7. pii: 13993003.04361-2020.
    PubMed     Abstract available


  62. COLAK Y, Lange P
    Interpreting blood eosinophil counts in health and obstructive lung disease.
    Eur Respir J. 2022;59.
    PubMed    


  63. BENSON VS, Hartl S, Barnes N, Galwey N, et al
    Blood eosinophil counts in the general population and airways disease: a comprehensive review and meta-analysis.
    Eur Respir J. 2022;59.
    PubMed     Abstract available


    December 2021
  64. RAITA Y, Perez-Losada M, Freishtat RJ, Hahn A, et al
    Nasopharyngeal metatranscriptome profiles of infants with bronchiolitis and risk of childhood asthma: a multicentre prospective study.
    Eur Respir J. 2021 Dec 16. pii: 13993003.02293-2021.
    PubMed     Abstract available


  65. PORSBJERG C, Nieto-Fontarigo JJ, Cerps S, Ramu S, et al
    Phenotype and severity of asthma determines bronchial epithelial immune responses to a viral mimic.
    Eur Respir J. 2021 Dec 16. pii: 13993003.02333-2021.
    PubMed     Abstract available


  66. AGARWAL R, Muthu V
    Prednisolone plus itraconazole in acute-stage allergic bronchopulmonary aspergillosis complicating asthma.
    Eur Respir J. 2021 Dec 9. pii: 13993003.02989-2021.
    PubMed    


  67. HAVETTE A, Regard L, Roche N, Burgel PR, et al
    Prednisolone plus itraconazole in acute-stage allergic bronchopulmonary aspergillosis complicating asthma: is the benefit worth the risk?
    Eur Respir J. 2021 Dec 9. pii: 13993003.02924-2021.
    PubMed    


  68. KRUIZINGA MD, Essers E, Stuurman FE, Yavuz Y, et al
    Clinical validation of digital biomarkers for pediatric patients with asthma and cystic fibrosis - Potential for clinical trials and clinical care.
    Eur Respir J. 2021 Dec 9. pii: 13993003.00208-2021.
    PubMed     Abstract available


  69. GURDENIZ G, Ernst M, Rago D, Kim M, et al
    Neonatal metabolome of cesarean section and risk of childhood asthma.
    Eur Respir J. 2021 Dec 9. pii: 13993003.02406-2021.
    PubMed     Abstract available


  70. RYAN D, Sabroe I
    Identifying and addressing health inequalities in asthma care.
    Eur Respir J. 2021;58.
    PubMed    


  71. PAPAIOANNOU AI, Photiades A, Gaga M
    Using placebo-controlled trials to define predictors of future exacerbations in severe asthma patients.
    Eur Respir J. 2021;58.
    PubMed    


  72. CHALMERS JD, Keir HR
    Less is more? Antibiotic treatment duration for exacerbations of bronchiectasis.
    Eur Respir J. 2021;58.
    PubMed    


  73. KURODA N, Shiroshita A, Tsujimoto Y
    Room for methodological improvement in gait speed study for COPD patients.
    Eur Respir J. 2021;58.
    PubMed    


  74. WALSH JA, Barker RE, Kon SSC, Jones SE, et al
    Reply to: Room for methodological improvement in gait speed study for COPD patients.
    Eur Respir J. 2021;58.
    PubMed    


  75. LIU S, Lim YH, Pedersen M, Jorgensen JT, et al
    Long-term air pollution and road traffic noise exposure and COPD: the Danish Nurse Cohort.
    Eur Respir J. 2021;58.
    PubMed     Abstract available


  76. HERNANDEZ CORDERO AI, Yang CX, Milne S, Li X, et al
    Epigenetic blood biomarkers of ageing and mortality in COPD.
    Eur Respir J. 2021;58.
    PubMed    


  77. BEDI P, Cartlidge MK, Zhang Y, Turnbull K, et al
    Feasibility of shortening intravenous antibiotic therapy for bronchiectasis based on bacterial load: a proof-of-concept randomised controlled trial.
    Eur Respir J. 2021;58.
    PubMed     Abstract available


  78. PARK S, Lee S, Kim Y, Cho S, et al
    Kidney function and obstructive lung disease: a bidirectional Mendelian randomisation study.
    Eur Respir J. 2021;58.
    PubMed     Abstract available


    November 2021
  79. ABDEL-AZIZ MI, Vijverberg SJH, Neerincx AH, Brinkman P, et al
    A multi-omics approach to delineate sputum microbiome-associated asthma inflammatory phenotypes.
    Eur Respir J. 2021 Nov 25. pii: 13993003.02603-2021.
    PubMed    


  80. REINKE SN, Naz S, Chaleckis R, Gallart-Ayala H, et al
    Urinary metabotype of severe asthma evidences decreased carnitine metabolism independent of oral corticosteroid treatment in the U-BIOPRED study.
    Eur Respir J. 2021 Nov 25. pii: 13993003.01733-2021.
    PubMed     Abstract available


  81. JAYARAM L, Vandal AC, Chang C, Lewis C, et al
    Tiotropium treatment for bronchiectasis: a randomised, placebo-controlled, crossover trial.
    Eur Respir J. 2021 Nov 18. pii: 13993003.02184-2021.
    PubMed     Abstract available


  82. MIKUS MS, Kolmert J, Andersson LI, Ostling J, et al
    Plasma proteins elevated in severe asthma despite oral steroid use and unrelated to Type-2 inflammation.
    Eur Respir J. 2021 Nov 4. pii: 13993003.00142-2021.
    PubMed     Abstract available


  83. STRIDSMAN C, Vanfleteren LEGW, Konradsen JR, Axelsson Fisk S, et al
    Predictors of severe COVID-19 in a registry-based Swedish cohort of patients with COPD.
    Eur Respir J. 2021;58.
    PubMed    


  84. OLIVER BG
    Food for thought: why is there more airway smooth muscle in asthma?
    Eur Respir J. 2021;58.
    PubMed    


  85. MANNINO DM
    Asthma, COPD and their overlap: coexistence or something more?
    Eur Respir J. 2021;58.
    PubMed    


  86. WALSH JA, Barker RE, Kon SSC, Jones SE, et al
    Gait speed and adverse outcomes following hospitalised exacerbation of COPD.
    Eur Respir J. 2021;58.
    PubMed     Abstract available


  87. FINNEGAN SL, Harrison OK, Harmer CJ, Herigstad M, et al
    Breathlessness in COPD: linking symptom clusters with brain activity.
    Eur Respir J. 2021;58.
    PubMed     Abstract available


    October 2021
  88. PIJNENBURG MW, Frey U, De Jongste JC, Saglani S, et al
    Childhood asthma- pathogenesis and phenotypes.
    Eur Respir J. 2021 Oct 28. pii: 13993003.00731-2021.
    PubMed     Abstract available


  89. ELSEY L, Pantin T, Holmes LJ, Tavernier G, et al
    Outcomes over the first two years of treatment with mepolizumab in severe asthma.
    Eur Respir J. 2021 Oct 28. pii: 13993003.01313-2021.
    PubMed     Abstract available


  90. SIBILA O, Laserna E, Shoemark A, Perea L, et al
    Heterogeneity of treatment response in bronchiectasis clinical trials.
    Eur Respir J. 2021 Oct 21. pii: 13993003.00777-2021.
    PubMed     Abstract available


  91. REDDEL HK, Bacharier LB, Bateman ED, Brightling CE, et al
    Global Initiative for Asthma (GINA) Strategy 2021 - Executive summary and rationale for key changes.
    Eur Respir J. 2021 Oct 19. pii: 13993003.02730-2021.
    PubMed     Abstract available


  92. CHAN R, Misirovs R, Lipworth B
    Repeatability of impulse oscillometry in patients with severe asthma.
    Eur Respir J. 2021 Oct 8. pii: 13993003.01679-2021.
    PubMed    


  93. SUN Y, Xia PF, Xie J, Mustieles V, et al
    Association of blood trihalomethane concentrations with asthma in U.S. adolescents: nationally representative cross-sectional study.
    Eur Respir J. 2021 Oct 8. pii: 13993003.01440-2021.
    PubMed     Abstract available


  94. PORSBJERG C, Maitland-van der Zee AH, Brusselle G, Canonica GW, et al
    3TR: a pan-European cross-disease research consortium aimed at improving personalised biological treatment of asthma and COPD.
    Eur Respir J. 2021;58.
    PubMed    


  95. CHANG AB, Boyd J, Bush A, Grimwood K, et al
    Children's Bronchiectasis Education Advocacy and Research Network (Child-BEAR-Net): an ERS Clinical Research Collaboration on improving outcomes of children and adolescents with bronchiectasis.
    Eur Respir J. 2021;58.
    PubMed    


  96. KEIR HR, Chalmers JD
    IL-6 trans-signalling: how Haemophilus surfs the NET to amplify inflammation in COPD.
    Eur Respir J. 2021;58.
    PubMed    


  97. PETOUSI N, Wooden A, Russell REK
    A new piece in the puzzle: the eosinophil and the development of COPD.
    Eur Respir J. 2021;58.
    PubMed    


  98. WINSLOW S, Odqvist L, Diver S, Riise R, et al
    Multi-omics links IL-6 trans-signalling with neutrophil extracellular trap formation and Haemophilus infection in COPD.
    Eur Respir J. 2021;58.
    PubMed     Abstract available


  99. PHILIP J, Collins A, Smallwood N, Chang YK, et al
    Referral criteria to palliative care for patients with respiratory disease: a systematic review.
    Eur Respir J. 2021;58.
    PubMed     Abstract available


  100. PARK HY, Chang Y, Kang D, Hong YS, et al
    Blood eosinophil counts and the development of obstructive lung disease: the Kangbuk Samsung Health Study.
    Eur Respir J. 2021;58.
    PubMed     Abstract available


  101. HIRAI K, Tanaka A, Sato H, Sato Y, et al
    Effect of surgical mask on exercise capacity in COPD: a randomised crossover trial.
    Eur Respir J. 2021;58.
    PubMed    


    September 2021
  102. MIURA S, Iwamoto H, Omori K, Yamaguchi K, et al
    Accelerated decline in lung function in adults with a history of remitted childhood asthma.
    Eur Respir J. 2021 Sep 29. pii: 13993003.00305-2021.
    PubMed     Abstract available


  103. BATEMAN ED, Price DB, Wang HC, Khattab A, et al
    Short-acting beta2-agonist prescriptions are associated with poor clinical outcomes of asthma: the multi-country, cross-sectional SABINA III study.
    Eur Respir J. 2021 Sep 24. pii: 13993003.01402-2021.
    PubMed     Abstract available


  104. BUSBY J, Matthews JG, Chaudhuri R, Pavord ID, et al
    Factors affecting adherence with treatment advice in a clinical trial of patients with severe asthma.
    Eur Respir J. 2021 Sep 24. pii: 13993003.00768-2021.
    PubMed     Abstract available


  105. PANAGOU P, Tzilas V, Bouros D
    "Dynamic (C dyn) lung compliance in non-smokers with asthma and fixed, non-reversible airflow obstruction" ERJ 2021 58: 2004400.
    Eur Respir J. 2021 Sep 24. pii: 13993003.02361-2021.
    PubMed    


  106. AGARWAL R, Muthu V, Sehgal IS, Dhooria S, et al
    A randomised trial of prednisolone versus prednisolone and itraconazole in acute-stage allergic bronchopulmonary aspergillosis complicating asthma.
    Eur Respir J. 2021 Sep 9. pii: 13993003.01787-2021.
    PubMed     Abstract available


  107. VAN HULST G, Jorssen J, Jacobs N, Henket M, et al
    Anti-IL-5 mepolizumab minimally influences residual blood eosinophils in severe asthma.
    Eur Respir J. 2021 Sep 2. pii: 13993003.00935-2021.
    PubMed     Abstract available


  108. GREDIC M, Wu CY, Hadzic S, Pak O, et al
    Myeloid cell-specific deletion of inducible nitric oxide synthase protects against smoke-induced pulmonary hypertension in mice.
    Eur Respir J. 2021 Sep 2. pii: 13993003.01153-2021.
    PubMed     Abstract available


  109. GARCIA-LARSEN V
    Omega-3 polyunsaturated fatty acids and FADS genotype: is personalised prevention of asthma on the horizon?
    Eur Respir J. 2021;58.
    PubMed    


  110. RUFFLES T, Lipworth B, Mukhopadhyay S
    Considerations of a real life pragmatic clinical trial in adolescent asthma.
    Eur Respir J. 2021;58.
    PubMed    


  111. VAN BOVEN JFM, Dierick BJH, Usmani OS
    When biology meets behaviour: can medication adherence mask the contribution of pharmacogenetic effects in asthma?
    Eur Respir J. 2021;58.
    PubMed    


  112. LOUIS R, Louis G, Bonhomme O
    NOVELTY: a landmark study in phenotyping and endotyping chronic obstructive airway diseases in real clinical practice.
    Eur Respir J. 2021;58.
    PubMed    


  113. BAFADHEL M, Barnes N, Bourke SC, Compton C, et al
    A single blood eosinophil count measurement is as good as two for prediction of ICS treatment response in the IMPACT trial.
    Eur Respir J. 2021;58.
    PubMed    


    August 2021
  114. ROFFEL MP, Boudewijn IM, van Nijnatten JLL, Faiz A, et al
    Identification of asthma associated microRNAs in bronchial biopsies.
    Eur Respir J. 2021 Aug 26. pii: 13993003.01294-2021.
    PubMed     Abstract available


  115. KEIR HR, Shoemark A, Huang JTJ, Chalmers JD, et al
    SPLUNC1 is a novel marker of disease severity and airway infection in bronchiectasis.
    Eur Respir J. 2021 Aug 19. pii: 13993003.01840-2021.
    PubMed    


  116. SUNJAYA AP, Allida SM, Di Tanna GL, Jenkins CR, et al
    Asthma and Coronavirus Disease 2019 Risk: a systematic review and meta-analysis.
    Eur Respir J. 2021 Aug 12. pii: 13993003.01209-2021.
    PubMed     Abstract available


  117. WU M, Xie J, Wang Y, Tian Y, et al
    Greenness and eosinophilic asthma: Findings from the UK Biobank.
    Eur Respir J. 2021 Aug 12. pii: 13993003.01597-2021.
    PubMed    


  118. AFSHAR-MOHAJER N, Wu TD, Shade R, Brigham E, et al
    Obesity, tidal volume, and pulmonary deposition of fine particulate matter in children with asthma.
    Eur Respir J. 2021 Aug 12. pii: 13993003.00209-2021.
    PubMed     Abstract available


  119. IZQUIERDO JL, Soriano JB
    Biologics may have a beneficial effect in asthma patients with COVID-19.
    Eur Respir J. 2021;58.
    PubMed    


  120. ZEDER K, Avian A, Bachmaier G, Douschan P, et al
    Elevated pulmonary vascular resistance predicts mortality in COPD patients.
    Eur Respir J. 2021;58.
    PubMed    


  121. HARTLEY T, Lane ND, Steer J, Elliott MW, et al
    The Noninvasive Ventilation Outcomes (NIVO) score: prediction of in-hospital mortality in exacerbations of COPD requiring assisted ventilation.
    Eur Respir J. 2021;58.
    PubMed     Abstract available


  122. BROXTERMAN RM, Wagner PD, Richardson RS
    Exercise training in COPD: muscle O2 transport plasticity.
    Eur Respir J. 2021;58.
    PubMed     Abstract available


    July 2021
  123. WECKMANN M, Bahmer T, Bulow Sand JM, Rank Ronnow S, et al
    COL4A3 is degraded in allergic asthma and degradation predicts response to anti-IgE therapy.
    Eur Respir J. 2021 Jul 29. pii: 13993003.03969-2020.
    PubMed     Abstract available


  124. BUSSE WW, Paggiaro P, Munoz X, Casale TB, et al
    Impact of baseline patient characteristics on dupilumab efficacy in type 2 asthma.
    Eur Respir J. 2021 Jul 29. pii: 13993003.04605-2020.
    PubMed    


  125. HAN YY, Forno E, Bacharier LB, Phipatanakul W, et al
    Vitamin D supplementation, lung function, and asthma control in children with asthma and low vitamin D levels.
    Eur Respir J. 2021 Jul 29. pii: 13993003.00989-2021.
    PubMed    


  126. CORREN J, Katelaris CH, Castro M, Maspero JF, et al
    Effect of exacerbation history on clinical response to dupilumab in moderate-severe uncontrolled asthma.
    Eur Respir J. 2021 Jul 15. pii: 13993003.04498-2020.
    PubMed     Abstract available


  127. WARK PA, Pathinayake PS, Eapen MS, Sohal SS, et al
    Asthma, COPD and SARS-CoV-2 infection (COVID-19): potential mechanistic insights.
    Eur Respir J. 2021 Jul 8. pii: 13993003.00920-2021.
    PubMed    


  128. SUNDE RB, Thorsen J, Pedersen CT, Stokholm J, et al
    Prenatal tobacco exposure and risk of asthma and allergy outcomes in childhood.
    Eur Respir J. 2021 Jul 8. pii: 13993003.00453-2021.
    PubMed     Abstract available


  129. RAMAKRISHNAN S, Couillard S
    Antibiotics for asthma attacks: masking uncertainty.
    Eur Respir J. 2021;58.
    PubMed    


  130. MILNE S, Li X, Yang CX, Leitao Filho FS, et al
    Inhaled corticosteroids downregulate SARS-CoV-2-related genes in COPD: results from a randomised controlled trial.
    Eur Respir J. 2021;58.
    PubMed    


  131. YOUNG RP, Scott RJ
    Statins as adjunct therapy in COPD: is it time to target innate immunity and cardiovascular risk?
    Eur Respir J. 2021;58.
    PubMed    


  132. LEVY L, Huszti E, Berra G, Renaud-Picard B, et al
    The accuracy of forced vital capacity for diagnosing restrictive allograft syndrome and mixed phenotype of chronic lung allograft dysfunction.
    Eur Respir J. 2021;58.
    PubMed    


  133. RUTTING S, Badal T, Wallis R, Schoeffel RE, et al
    Long-term variability of oscillatory impedance in stable obstructive airways disease.
    Eur Respir J. 2021;58.
    PubMed    


  134. SCHENK P, Spiel AO, Huttinger F, Gmeiner M, et al
    Can simvastatin reduce COPD exacerbations? A randomised double-blind controlled study.
    Eur Respir J. 2021;58.
    PubMed     Abstract available


  135. EVANGELOPOULOS D, Chatzidiakou L, Walton H, Katsouyanni K, et al
    Personal exposure to air pollution and respiratory health of COPD patients in London.
    Eur Respir J. 2021;58.
    PubMed     Abstract available


    June 2021
  136. MOORE WC, Kornmann O, Humbert M, Poirier C, et al
    Stopping versus continuing long-term mepolizumab treatment in severe eosinophilic asthma (COMET study).
    Eur Respir J. 2021 Jun 25. pii: 13993003.00396-2021.
    PubMed     Abstract available


  137. KRAFT M, Brusselle G, Mark FitzGerald J, Pavord ID, et al
    Patient characteristics, biomarkers, and exacerbation risk in severe, uncontrolled asthma.
    Eur Respir J. 2021 Jun 10. pii: 13993003.00413-2021.
    PubMed     Abstract available


  138. THURSTON GD, Lee A
    Evidence of air pollution exposure and new asthma onset: further justification for cleaner air.
    Eur Respir J. 2021;57.
    PubMed    


  139. WEATHERALL M
    Improving adherence to asthma medications: same-old, same-old?
    Eur Respir J. 2021;57.
    PubMed    


  140. LIU S, Jorgensen JT, Ljungman P, Pershagen G, et al
    Long-term exposure to low-level air pollution and incidence of asthma: the ELAPSE project.
    Eur Respir J. 2021;57.
    PubMed     Abstract available


  141. KUNISAKI KM, Sin DD
    Methylxanthines in COPD: yes to caffeine, no to theophylline.
    Eur Respir J. 2021;57.
    PubMed    


  142. HULL JH, Jackson AR, Ranson C, Brown F, et al
    The benefits of a systematic assessment of respiratory health in illness-susceptible athletes.
    Eur Respir J. 2021;57.
    PubMed     Abstract available


  143. JENKINS CR, Wen FQ, Martin A, Barnes PJ, et al
    The effect of low-dose corticosteroids and theophylline on the risk of acute exacerbations of COPD: the TASCS randomised controlled trial.
    Eur Respir J. 2021;57.
    PubMed     Abstract available


  144. SANTOS LD, Antunes KH, Muraro SP, de Souza GF, et al
    TNF-mediated alveolar macrophage necroptosis drives disease pathogenesis during respiratory syncytial virus infection.
    Eur Respir J. 2021;57.
    PubMed     Abstract available


  145. BENINCASA G, DeMeo DL, Glass K, Silverman EK, et al
    Epigenetics and pulmonary diseases in the horizon of precision medicine: a review.
    Eur Respir J. 2021;57.
    PubMed     Abstract available


    May 2021
  146. JENDZJOWSKY N, Laing A, Malig M, Matyas J, et al
    Long-term modulation of airway remodeling in severe asthma following bronchial thermoplasty.
    Eur Respir J. 2021 May 28. pii: 13993003.00622-2021.
    PubMed     Abstract available


  147. BENLALA I, Dournes G, Girodet PO, Benkert T, et al
    Evaluation of bronchial wall thickness in asthma using magnetic resonance imaging.
    Eur Respir J. 2021 May 28. pii: 13993003.00329-2021.
    PubMed     Abstract available


  148. SVERRILD A, Hansen S, Hvidtfeldt M, Clausson CM, et al
    The effect of tezepelumab on airway hyperresponsiveness to mannitol in asthma (UPSTREAM).
    Eur Respir J. 2021 May 28. pii: 13993003.01296-2021.
    PubMed     Abstract available


  149. HAKANSSON KEJ, Backer V, Suppli Ulrik C
    Socioeconomic biases in asthma control and specialist referral of possible severe asthma.
    Eur Respir J. 2021 May 13. pii: 13993003.00741-2021.
    PubMed     Abstract available


  150. JOHANSSON H, Wollmer P, Sundstrom J, Janson C, et al
    Bronchodilator response in FOT parameters in middle-aged adults from SCAPIS - normal values and relation to asthma and wheezing.
    Eur Respir J. 2021 May 6. pii: 13993003.00229-2021.
    PubMed    


  151. BRUGIERE O, Verleden SE
    Putting the spotlight on macrophage-derived cathepsin in the pathophysiology of obliterative bronchiolitis.
    Eur Respir J. 2021;57.
    PubMed    


  152. TAN WC, Bourbeau J, Nadeau G, Wang W, et al
    High eosinophil counts predict decline in FEV1: results from the CanCOLD study.
    Eur Respir J. 2021;57.
    PubMed     Abstract available


  153. MORRONE C, Smirnova NF, Jeridi A, Kneidinger N, et al
    Cathepsin B promotes collagen biosynthesis, which drives bronchiolitis obliterans syndrome.
    Eur Respir J. 2021;57.
    PubMed     Abstract available


    April 2021
  154. MCLEESE RH, Spinou A, Alfahl Z, Tsagris M, et al
    Psychometrics of HRQoL questionnaires in bronchiectasis: A systematic review and meta-analysis.
    Eur Respir J. 2021 Apr 22. pii: 13993003.00025-2021.
    PubMed     Abstract available


  155. GAILLARD EA, Kuehni CE, Turner S, Goutaki M, et al
    European Respiratory Society clinical practice guidelines for the diagnosis of asthma in children aged 5-16 years.
    Eur Respir J. 2021 Apr 19. pii: 13993003.04173-2020.
    PubMed     Abstract available


  156. DURACK T, Chapman DG, Rutting S, Thamrin C, et al
    Dynamic compliance and reactance in older non-smokers with asthma and fixed airflow obstruction.
    Eur Respir J. 2021 Apr 16. pii: 13993003.04400-2020.
    PubMed    


  157. MARCON A, Locatelli F, Dharmage SC, Svanes C, et al
    The coexistence of asthma and COPD: risk factors, clinical history and lung function trajectories.
    Eur Respir J. 2021 Apr 16. pii: 13993003.04656-2020.
    PubMed     Abstract available


  158. ESTEVES P, Blanc L, Celle A, Dupin I, et al
    Crucial role of fatty acid oxidation in asthmatic bronchial smooth muscle remodelling.
    Eur Respir J. 2021 Apr 8. pii: 13993003.04252-2020.
    PubMed     Abstract available


  159. LUCCHETTI D, Santini G, Perelli L, Ricciardi-Tenore C, et al
    Detection and characterization of extracellular vesicles in exhaled breath condensate and sputum of COPD and severe asthma patients.
    Eur Respir J. 2021 Apr 1. pii: 13993003.03024-2020.
    PubMed    


  160. TALAEI M, Hughes DA, Mahmoud O, Emmett PM, et al
    Dietary intake of vitamin A, lung function, and incident asthma in childhood.
    Eur Respir J. 2021 Apr 1. pii: 13993003.04407-2020.
    PubMed     Abstract available


  161. SPITZER C, Ewert R, Volzke H, Frenzel S, et al
    Childhood maltreatment and lung function: findings from the general population.
    Eur Respir J. 2021;57.
    PubMed     Abstract available


    March 2021
  162. HIGBEE DH, Nava GW, Kwong ASF, Dodd JW, et al
    The impact of asthma on mental health & wellbeing during COVID-19 lockdown.
    Eur Respir J. 2021 Mar 25. pii: 13993003.04497-2020.
    PubMed    


  163. BRUSSELLE G, Nicolini G, Santoro L, Guastalla D, et al
    BDP/formoterol MART asthma exacerbation benefit increases with blood eosinophil level.
    Eur Respir J. 2021 Mar 18. pii: 13993003.040982020.
    PubMed    


  164. PRICE OJ, Kucera KL, Price HM, Drezner JA, et al
    Asthma-related sudden death in athletes: A retrospective analysis of the U.S. NCCSIR database (1982-2018).
    Eur Respir J. 2021 Mar 7. pii: 13993003.00088-2021.
    PubMed    


  165. WEE LE, Conceicao EP, Tan JY, Sim JXY, et al
    Reduction in asthma admissions during the COVID-19 pandemic: consequence of public health measures in Singapore.
    Eur Respir J. 2021 Mar 2. pii: 13993003.04493-2020.
    PubMed    


  166. KNIHTILA HM, Kelly RS, Brustad N, Huang M, et al
    Maternal 17q21 genotype influences prenatal vitamin D effects on offspring asthma/recurrent wheeze.
    Eur Respir J. 2021 Mar 2. pii: 13993003.02012-2020.
    PubMed     Abstract available


  167. BOTTLE A, Quint J
    COPD: still an unpredictable journey.
    Eur Respir J. 2021;57.
    PubMed    


  168. CHAPMAN DG, King GG
    To recline is to relax? Not when you have COPD!
    Eur Respir J. 2021;57.
    PubMed    


  169. COLAK Y
    Cardiac disease from accelerated FEV1 decline and acute exacerbations: time to rethink comorbidities in COPD.
    Eur Respir J. 2021;57.
    PubMed    


  170. CELLI B, Locantore N, Yates JC, Bakke P, et al
    Markers of disease activity in COPD: an 8-year mortality study in the ECLIPSE cohort.
    Eur Respir J. 2021;57.
    PubMed     Abstract available


  171. WANG G, Hallberg J, Um Bergstrom P, Janson C, et al
    Assessment of chronic bronchitis and risk factors in young adults: results from BAMSE.
    Eur Respir J. 2021;57.
    PubMed     Abstract available


  172. WING K, Williamson E, Carpenter JR, Wise L, et al
    Real world effects of COPD medications: a cohort study with validation against results from randomised controlled trials.
    Eur Respir J. 2021;57.
    PubMed     Abstract available


  173. DI CAMPLI MP, Azouz A, Assabban A, Scaillet J, et al
    The mononuclear phagocyte system contributes to fibrosis in post-transplant obliterans bronchiolitis.
    Eur Respir J. 2021;57.
    PubMed     Abstract available


  174. TIEW PY, Dicker AJ, Keir HR, Poh ME, et al
    A high-risk airway mycobiome is associated with frequent exacerbation and mortality in COPD.
    Eur Respir J. 2021;57.
    PubMed     Abstract available


  175. ELBEHAIRY AF, Faisal A, McIsaac H, Domnik NJ, et al
    Mechanisms of orthopnoea in patients with advanced COPD.
    Eur Respir J. 2021;57.
    PubMed     Abstract available


  176. WHITTAKER HR, Bloom C, Morgan A, Jarvis D, et al
    Accelerated FEV1 decline and risk of cardiovascular disease and mortality in a primary care population of COPD patients.
    Eur Respir J. 2021;57.
    PubMed     Abstract available


    February 2021
  177. MASOLI M, Lanario JW, Hyland ME, Menzies-Gow A, et al
    The Severe Asthma Questionnaire: sensitivity to change and minimal clinically important difference (MCID).
    Eur Respir J. 2021 Feb 25. pii: 13993003.00300-2021.
    PubMed    


  178. REDDEL HK, Vestbo J, Agusti A, Anderson GP, et al
    Heterogeneity within and between physician-diagnosed asthma and/or COPD: NOVELTY cohort.
    Eur Respir J. 2021 Feb 25. pii: 13993003.03927-2020.
    PubMed     Abstract available


  179. CHANG AB, Fortescue R, Grimwood K, Alexopoulou E, et al
    Task Force report: European Respiratory Society guidelines for the management of children and adolescents with bronchiectasis.
    Eur Respir J. 2021 Feb 11. pii: 13993003.02990-2020.
    PubMed     Abstract available


  180. BUSSE WW, Kraft M, Rabe KF, Deniz Y, et al
    Understanding the key issues in the treatment of uncontrolled persistent asthma with type 2 inflammation.
    Eur Respir J. 2021 Feb 4. pii: 13993003.03393-2020.
    PubMed     Abstract available


  181. WANG R, Alahmadi F, Niven R, Fowler SJ, et al
    Same-day repeatability of fractional exhaled nitric oxide in severe asthma.
    Eur Respir J. 2021 Feb 4. pii: 13993003.03391-2020.
    PubMed    


  182. REDDEL HK
    Reply: About the recommendation of the GINA strategy report on asthma step 1.
    Eur Respir J. 2021;57.
    PubMed    


  183. FERRETTI S, Gelsomino M, Miceli Sopo S
    About the recommendation of the GINA strategy report on asthma step 1.
    Eur Respir J. 2021;57.
    PubMed    


  184. PENN RB
    Honing in on the effectors of oxidative stress in the asthmatic lung: oxidised phosphatidylcholines.
    Eur Respir J. 2021;57.
    PubMed    


  185. BRUSASCO C, Corradi F, Di Domenico A, Raggi F, et al
    Continuous positive airway pressure in COVID-19 patients with moderate-to-severe respiratory failure.
    Eur Respir J. 2021;57.
    PubMed    


  186. STOCKLEY RA
    COPD frequent exacerbators: time for the recycle bin?
    Eur Respir J. 2021;57.
    PubMed    


  187. JANSON C, Lisspers K, Stallberg B, Johansson G, et al
    Osteoporosis and fracture risk associated with inhaled corticosteroid use among Swedish COPD patients: the ARCTIC study.
    Eur Respir J. 2021;57.
    PubMed     Abstract available


  188. CASS SP, Yang Y, Xiao J, McGrath JJC, et al
    Current smoking status is associated with reduced sputum immunoglobulin M and G expression in COPD.
    Eur Respir J. 2021;57.
    PubMed    


  189. SADATSAFAVI M, McCormack J, Petkau J, Lynd LD, et al
    Should the number of acute exacerbations in the previous year be used to guide treatments in COPD?
    Eur Respir J. 2021;57.
    PubMed     Abstract available


    January 2021
  190. ROGLIANI P, Ritondo BL, Calzetta L
    Triple therapy in uncontrolled asthma: a network meta-analysis of Phase III studies.
    Eur Respir J. 2021 Jan 28. pii: 13993003.04233-2020.
    PubMed     Abstract available


  191. GIAM YH, Shoemark A, Chalmers JD
    Neutrophil dysfunction in bronchiectasis: an emerging role for immunometabolism.
    Eur Respir J. 2021 Jan 28. pii: 13993003.03157-2020.
    PubMed     Abstract available


  192. TALAEI M, Sdona E, Calder PC, Jones LR, et al
    Intake of n-3 polyunsaturated fatty acids in childhood, FADS genotype, and incident asthma.
    Eur Respir J. 2021 Jan 28. pii: 13993003.03633-2020.
    PubMed     Abstract available


  193. BEAULIEU D, Attwe A, Breau M, Lipskaia L, et al
    Phospholipase A2-Receptor 1 Promotes Lung-Cell Senescence and Emphysema in Obstructive Lung Disease.
    Eur Respir J. 2021 Jan 28. pii: 13993003.00752-2020.
    PubMed     Abstract available


  194. RUFFLES T, Jones CJ, Palmer C, Turner S, et al
    Asthma prescribing according to Arg16Gly beta-2 genotype: a randomised trial in adolescents.
    Eur Respir J. 2021 Jan 21. pii: 13993003.04107-2020.
    PubMed     Abstract available


  195. MAGNAYE KM, Naughton KA, Huffman J, Hogarth DK, et al
    A-to-I editing of miR-200b-3p in airway cells is associated with moderate-to-severe asthma.
    Eur Respir J. 2021 Jan 14. pii: 13993003.03862-2020.
    PubMed     Abstract available


  196. MURRAY CS, Lucas SJ, Blakey J, Kaplan A, et al
    A real-life comparative effectiveness study into the addition of antibiotics to the management of asthma exacerbations in primary care.
    Eur Respir J. 2021 Jan 8. pii: 13993003.03599-2020.
    PubMed     Abstract available


  197. SIBILA O
    Reducing Pseudomonas sputum density in bronchiectasis.
    Eur Respir J. 2021;57.
    PubMed    


  198. MOMEN NC, Liu X
    Maternal antibiotic use during pregnancy and asthma in children: population-based cohort study and sibling design.
    Eur Respir J. 2021;57.
    PubMed     Abstract available


  199. PLEASANTS RA, Tilley SL, Hickey AJ, Usmani OS, et al
    User-life of ICS/LABA inhaler devices should be considered when prescribed as relievers.
    Eur Respir J. 2021;57.
    PubMed    


  200. SUNADOME H, Sato S, Matsumoto H, Murase K, et al
    Similar distribution of peripheral blood eosinophil counts in European and East Asian populations from investigations of large-scale general population studies: the Nagahama Study.
    Eur Respir J. 2021;57.
    PubMed    


  201. LIN J, Huang N, Li J, Liu X, et al
    Cross-reactive antibodies against dust mite-derived enolase induce neutrophilic airway inflammation.
    Eur Respir J. 2021;57.
    PubMed     Abstract available


  202. GUIBERT N, Guilleminault L, Lepage B, Heluain V, et al
    Bronchial thermoplasty in patients with dynamic hyperinflation: results from the proof-of-concept HEAT trial.
    Eur Respir J. 2021;57.
    PubMed    


    December 2020
  203. EGER K, Bel EH
    Asthma and COVID-19: do we finally have answers?
    Eur Respir J. 2020 Dec 30. pii: 13993003.04451-2020.
    PubMed    


  204. MOORE A, Preece A, Sharma R, Heaney LG, et al
    A randomised controlled trial of the effect of a connected inhaler system on medication adherence in uncontrolled asthmatic patients.
    Eur Respir J. 2020 Dec 17. pii: 13993003.03103-2020.
    PubMed     Abstract available


  205. KRUG J, Kiefer A, Koelle J, Vuorinen T, et al
    TLR 7/8 regulates Type I and Type III Interferon Signalling in RV1b induced Allergic Asthma.
    Eur Respir J. 2020 Dec 10. pii: 13993003.01562-2020.
    PubMed     Abstract available


  206. LIU S, Jorgensen JT, Ljungman P, Pershagen G, et al
    Long-term exposure to low-level air pollution and incidence of asthma: the ELAPSE project.
    Eur Respir J. 2020 Dec 10. pii: 13993003.030992020.
    PubMed     Abstract available


  207. LONGO C, Blais L, Brownell M, Quail JM, et al
    Association between asthma control trajectories in preschoolers and disease remission.
    Eur Respir J. 2020 Dec 10. pii: 13993003.01897-2020.
    PubMed     Abstract available


  208. HERNANDEZ-PACHECO N, Vijverberg SJ, Herrera-Luis E, Li J, et al
    Genome-wide association study of asthma exacerbations despite inhaled corticosteroids use.
    Eur Respir J. 2020 Dec 10. pii: 13993003.03388-2020.
    PubMed     Abstract available


  209. CHO PSP, Fletcher HV, Patel IS, Turner RD, et al
    Cough Hypersensitivity and Suppression in Chronic Obstructive Pulmonary Disease.
    Eur Respir J. 2020 Dec 10. pii: 13993003.03569-2020.
    PubMed     Abstract available


  210. O'BYRNE PM, Pavord ID
    A golden age of asthma research.
    Eur Respir J. 2020;56.
    PubMed    


  211. WALTERS EH, Shukla SD, Ward C
    Stability of eosinophilic inflammation in COPD bronchial biopsies.
    Eur Respir J. 2020;56.
    PubMed    


  212. HIGHAM A, Singh D
    Stability of eosinophilic inflammation in COPD bronchial biopsies.
    Eur Respir J. 2020;56.
    PubMed    


    November 2020
  213. CRICHTON ML, Dudgeon EK, Shoemark A, Chalmers JD, et al
    Validation of the Bronchiectasis Impact Measure (BIM) - a novel patient reported outcome measure.
    Eur Respir J. 2020 Nov 19. pii: 13993003.03156-2020.
    PubMed     Abstract available


  214. FARNE H, Singanayagam A
    Why asthma might surprisingly protect against poor outcomes in COVID-19.
    Eur Respir J. 2020 Nov 5. pii: 13993003.03045-2020.
    PubMed    


  215. IZQUIERDO JL, Almonacid C, Gonzalez Y, Del Rio-Bermudez C, et al
    The Impact of COVID-19 on Patients with Asthma.
    Eur Respir J. 2020 Nov 5. pii: 13993003.03142-2020.
    PubMed     Abstract available


  216. MERKUS PJ, Pijnenburg MW
    Diagnosing asthma in children or adolescents/young adults? It is time for a change! How timing is everything, also in clinical practice.
    Eur Respir J. 2020;56.
    PubMed    


  217. WHITMORE GA, Aaron SD
    Population-based case-finding to identify airflow obstruction in symptomatic adults at high risk for asthma and COPD.
    Eur Respir J. 2020;56.
    PubMed    


  218. PERRET JL, Vicendese D, Dharmage SC
    Population-based case-finding to identify airflow obstruction in symptomatic adults at high risk for asthma and COPD.
    Eur Respir J. 2020;56.
    PubMed    


  219. SAHANIC S, Boehm A, Pizzini A, Sonnweber T, et al
    Assessing self-medication for obstructive airway disease during COVID-19 using Google Trends.
    Eur Respir J. 2020;56.
    PubMed    


    October 2020
  220. O'BYRNE PM, Reddel HK, Beasley R
    The Management of Mild Asthma.
    Eur Respir J. 2020 Oct 22. pii: 13993003.03051-2020.
    PubMed     Abstract available


  221. YAN Q, Forno E, Herrera-Luis E, Pino-Yanes M, et al
    A genome-wide association study of severe asthma exacerbations in Latino children and adolescents.
    Eur Respir J. 2020 Oct 22. pii: 13993003.02693-2020.
    PubMed     Abstract available


  222. HANON S, Brusselle G, Deschampheleire M, Louis R, et al
    COVID-19 and biologics in severe asthma: data from the Belgian Severe Asthma Registry.
    Eur Respir J. 2020 Oct 22. pii: 13993003.02857-2020.
    PubMed    


  223. PAPI A, Braithwaite I, Ebmeier S, Hancox B, et al
    Budesonide-formoterol reliever therapy in intermittent versus mild persistent asthma.
    Eur Respir J. 2020 Oct 15. pii: 13993003.03064-2020.
    PubMed    


  224. ILMARINEN P, Pardo A, Tuomisto LE, Vahatalo I, et al
    Long-term prognosis of new adult-onset asthma in obese patients.
    Eur Respir J. 2020 Oct 8. pii: 13993003.01209-2020.
    PubMed     Abstract available


  225. HOLZ O, Waschki B, Watz H, Kirsten A, et al
    Breath volatile organic compounds and inflammatory markers in adult asthma patients - negative results from the ALLIANCE cohort.
    Eur Respir J. 2020 Oct 2. pii: 13993003.02127-2020.
    PubMed    


  226. KERMANI NZ, Pavlidis S, Xie J, Sun K, et al
    Instability of sputum molecular phenotypes in U-BIOPRED severe asthma.
    Eur Respir J. 2020 Oct 2. pii: 13993003.01836-2020.
    PubMed    


  227. O'NEILL C, Gibson PG, Heaney LG, Upham JW, et al
    The cost-effectiveness of azithromycin in reducing exacerbations in uncontrolled asthma.
    Eur Respir J. 2020 Oct 2. pii: 13993003.02436-2020.
    PubMed     Abstract available


  228. QUINN M, Turner AM
    Modernising case finding for alpha1-antitrypsin deficiency by DNA sequencing of COPD patients.
    Eur Respir J. 2020;56.
    PubMed    


  229. GLANVILLE AR
    Pseudomonas and risk factor mitigation for chronic lung allograft dysfunction.
    Eur Respir J. 2020;56.
    PubMed    


  230. CAVIEDES I, Soto R, Herth F
    The determination of ventilatory inefficiency at rest in COPD: the expected parameter.
    Eur Respir J. 2020;56.
    PubMed    


    September 2020
  231. CHOI YJ, Park JY, Lee HS, Suh J, et al
    Effect of Asthma and Asthma Medication on the Prognosis of Patients with COVID-19.
    Eur Respir J. 2020 Sep 25. pii: 13993003.02226-2020.
    PubMed     Abstract available


  232. ASHER MI, Garcia-Marcos L, Pearce NE, Strachan DP, et al
    "Trends in worldwide asthma prevalence".
    Eur Respir J. 2020 Sep 24. pii: 13993003.02094-2020.
    PubMed     Abstract available


  233. DAI X, Bui D, Perret JL, Lowe A, et al
    Exposure to household air pollution over 10 years is related to asthma and lung function decline.
    Eur Respir J. 2020 Sep 17. pii: 13993003.00602-2020.
    PubMed     Abstract available


  234. THOMPSON CA, Eslick SR, Berthon BS, Wood LG, et al
    Asthma medication use in obese and healthy weight asthma: systematic review/meta-analysis.
    Eur Respir J. 2020 Sep 17. pii: 13993003.00612-2020.
    PubMed     Abstract available


  235. PASCOE CD, Jha A, Ryu MH, Ragheb M, et al
    Allergen inhalation generates pro-inflammatory oxidised phosphatidylcholine associated with airway dysfunction.
    Eur Respir J. 2020 Sep 3. pii: 13993003.00839-2020.
    PubMed     Abstract available


  236. CALVERLEY PMA, Farre R
    Oscillometry: old physiology with a bright future.
    Eur Respir J. 2020;56.
    PubMed    


    August 2020
  237. CONNELL D, Shah A
    The contribution of Aspergillus fumigatus to COPD exacerbations: a "sensitive" topic.
    Eur Respir J. 2020;56.
    PubMed    


  238. NANZER AM, D'Ancona G, Kelly PA, Jackson DJ, et al
    Diagnosing adrenal insufficiency using ACTH stimulation test.
    Eur Respir J. 2020;56.
    PubMed    


  239. LIPWORTH B, Chan R, Kuo CR
    Diagnosing adrenal insufficiency using ACTH stimulation test.
    Eur Respir J. 2020;56.
    PubMed    


    July 2020
  240. JOHNSON MJ, Ekstrom M, Currow DC
    Observational studies and "the eye of the beholder".
    Eur Respir J. 2020;56.
    PubMed    


  241. KUGELMAN A
    High-flow nasal cannula therapy: can it be recommended as initial or rescue care for infants with moderate bronchiolitis in the paediatric ward?
    Eur Respir J. 2020;56.
    PubMed    


  242. CHALMERS JD, Miravitlles M
    Withdrawal of inhaled corticosteroids in COPD.
    Eur Respir J. 2020;56.
    PubMed    


  243. AGUSTI A
    Withdrawal of inhaled corticosteroids in COPD.
    Eur Respir J. 2020;56.
    PubMed    


  244. TRINKMANN F, Watz H, Herth FJF
    Why do we still cling to spirometry for assessing small airway function?
    Eur Respir J. 2020;56.
    PubMed    


  245. BOURDIN A, Gamez AS, Vachier I, Crestani B, et al
    LAM is another small airway disease: lessons from microCT.
    Eur Respir J. 2020;56.
    PubMed    


  246. ARSHAD SH, Kurukulaaratchy R, Zhang H, Hodgekiss C, et al
    Assessing small airway function for early detection of lung function impairment.
    Eur Respir J. 2020;56.
    PubMed    


    June 2020
  247. RUSSELL REK, Wang K
    Finding the true prevalence of obstructive lung disease: two steps forward and one step back.
    Eur Respir J. 2020;55.
    PubMed    


  248. ROCHE N, Tonia T, Miravitlles M, Vaccaro V, et al
    Expanding the spectrum of European Respiratory Society official scientific documents: short documents complement clinical practice guidelines, statements and technical standards.
    Eur Respir J. 2020;55.
    PubMed    


    May 2020
  249. DURAND P, Guiddir T, Kyheng C, Blanc F, et al
    A Randomised Trial of High-Flow Nasal Cannula in Infants with Moderate Bronchiolitis.
    Eur Respir J. 2020 May 7. pii: 13993003.01926-2019.
    PubMed     Abstract available


  250. STOLZ D, Miravitlles M
    The right treatment for the right patient with COPD: lessons from the IMPACT trial.
    Eur Respir J. 2020;55.
    PubMed    


  251. VEDEL-KROGH S
    The search for the "healthy" blood eosinophil count.
    Eur Respir J. 2020;55.
    PubMed    


  252. DE JONG CCM, Pedersen ESL, Mozun R, Goutaki M, et al
    A clinically significant bronchodilator response in children: how should it be measured?
    Eur Respir J. 2020;55.
    PubMed    


  253. GUEZGUEZ F, Ben Saad H
    What constitutes a "clinically significant" bronchodilator response in children?
    Eur Respir J. 2020;55.
    PubMed    


  254. HALPIN DMG, Dransfield MT, Han MK, Jones CE, et al
    The effect of exacerbation history on outcomes in the IMPACT trial.
    Eur Respir J. 2020;55.
    PubMed     Abstract available


  255. SCHEERENS C, Faes K, Pype P, Beernaert K, et al
    Earlier palliative home care is associated with patient-centred medical resource utilisation and lower costs in the last 30 days before death in COPD: a population-level decedent cohort study.
    Eur Respir J. 2020;55.
    PubMed     Abstract available


  256. MATHIOUDAKIS AG, Bikov A, Foden P, Lahousse L, et al
    Change in blood eosinophils following treatment with inhaled corticosteroids may predict long-term clinical response in COPD.
    Eur Respir J. 2020;55.
    PubMed     Abstract available


  257. HARTL S, Breyer MK, Burghuber OC, Ofenheimer A, et al
    Blood eosinophil count in the general population: typical values and potential confounders.
    Eur Respir J. 2020;55.
    PubMed     Abstract available


  258. JOGDAND P, Siddhuraj P, Mori M, Sanden C, et al
    Eosinophils, basophils and type 2 immune microenvironments in COPD-affected lung tissue.
    Eur Respir J. 2020;55.
    PubMed     Abstract available


  259. THULBORN SJ, Cane JL, Connolly C, Borg C, et al
    Evaluating the sensitivity and specificity of NEATstik technology compared to an activity-based immunoassay in sputum samples from participants with COPD.
    Eur Respir J. 2020;55.
    PubMed    


  260. LEONG P, Ruane LE, Phyland D, Koh J, et al
    Inspiratory vocal cord closure in COPD.
    Eur Respir J. 2020;55.
    PubMed    


    April 2020
  261. BEASLEY R, Braithwaite I, Semprini A, Kearns C, et al
    Achieving the balance between evidence and simplicity.
    Eur Respir J. 2020;55.
    PubMed    


  262. LIPWORTH B, Kuo CR, Chan R
    Making simple things complicated using anti-inflammatory reliever therapy.
    Eur Respir J. 2020;55.
    PubMed    


  263. DIVO MJ
    The adipose tissue and lung health: like many things in life, the extremes are not good.
    Eur Respir J. 2020;55.
    PubMed    


    March 2020
  264. SUISSA S, Ernst P
    Avoiding immortal time bias in observational studies.
    Eur Respir J. 2020;55.
    PubMed    


  265. RAYMAKERS AJN, Sadatsafavi M, Sin DD, FitzGerald JM, et al
    Avoiding immortal time bias in observational studies.
    Eur Respir J. 2020;55.
    PubMed    


  266. COLAK Y, Nordestgaard BG, Vestbo J, Lange P, et al
    Outcomes consequent to "early" COPD for interventional studies.
    Eur Respir J. 2020;55.
    PubMed    


  267. RENNARD SI
    Outcomes consequent to "early" COPD for interventional studies.
    Eur Respir J. 2020;55.
    PubMed    


  268. POLVERINO F, Soriano JB
    Small airways and early origins of COPD: pathobiological and epidemiological considerations.
    Eur Respir J. 2020;55.
    PubMed    


    November 2019
  269. BOUCLY A, Morelot-Panzini C, Garcia G, Weatherald J, et al
    Intensity and quality of exertional dyspnoea in patients with stable pulmonary hypertension.
    Eur Respir J. 2019 Nov 26. pii: 13993003.02108-2018.
    PubMed     Abstract available


  270. SUISSA S, Dell'Aniello S, Gonzalez AV, Ernst P, et al
    Inhaled corticosteroid use and the incidence of lung cancer in COPD.
    Eur Respir J. 2019 Nov 19. pii: 13993003.01720-2019.
    PubMed     Abstract available


    September 2019
  271. SPIRO SG, Shah PL, Rintoul RC, George J, et al
    Sequential screening for lung cancer in a high-risk group: randomised controlled trial.
    Eur Respir J. 2019 Sep 19. pii: 13993003.00581-2019.
    PubMed     Abstract available


  272. ROCHE N, Anzueto A, Bosnic Anticevich S, Kaplan A, et al
    The importance of real-life research in respiratory medicine: manifesto of the Respiratory Effectiveness Group: Endorsed by the International Primary Care Respiratory Group and the World Allergy Organization.
    Eur Respir J. 2019;54.
    PubMed    


    August 2019
  273. KRISHNA MT, Subramanian A, Adderley NJ, Zemedikun D, et al
    Allergic Diseases and Long Term Risk of Autoimmune Disorders: longitudinal cohort study and cluster analysis.
    Eur Respir J. 2019 Aug 14. pii: 13993003.00476-2019.
    PubMed     Abstract available


    April 2019
  274. PICHL A, Sommer N, Bednorz M, Seimetz M, et al
    Riociguat for treatment of pulmonary hypertension in COPD - a translational study.
    Eur Respir J. 2019 Apr 7. pii: 13993003.02445-2018.
    PubMed     Abstract available


  275. RAYMAKERS AJN, Sadatsafavi M, Sin DD, FitzGerald JM, et al
    Inhaled corticosteroids and the risk of lung cancer in chronic obstructive pulmonary disease (COPD): a population-based cohort study.
    Eur Respir J. 2019 Apr 7. pii: 13993003.01257-2018.
    PubMed     Abstract available


    December 2018
  276. NATHAN SD, Barbera JA, Gaine SP, Harari S, et al
    Pulmonary hypertension in chronic lung disease and hypoxia.
    Eur Respir J. 2018 Dec 13. pii: 13993003.01914-2018.
    PubMed     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Obstructive Lung Diseases is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: